Pippa Corrie, Consultant and Affiliated Associate Professor in Medical Oncology at Cambridge Unversity Hospitals NHS Foundation Trust, shared on LinkedIn:
“Very proud that our team at Addenbrooke’s Hospital has contributed to this precision vaccine trial first.
Looking forward to getting into the details when the full results are presented at the ESMO – European Society for Medical Oncology conference tomorrow.”
Interesting article about ESMO 2026:
